BMP2 and osteoporosis: In this study, we hypothesized that antiresorptive bisphosphonates (BPs) could serve as an ion-pairing counterpart to control and prolong the release of BMP2 via electrostatic interaction, thereby enhancing its therapeutic potential for osteoporosis.